Agree with what you have said . Think there are other ways to look into it that are important .
Execution of financials and general business it is a dud .
Science it is Nobel worthy .
Time , the devices have taken time to configure + the criteria for being a patient are detailed which also causes delay . Not making excuses think there is more going on as well .
Time B . We are close to having 3 month results of 10 patients , guess , by June of 2020 .
Risk/Reward the big tell at this time . $5000 gets 20 to 25 thous shares . If there is a glitch the stock could go to .08 and you lose 2500 .
If 10 are clean $25 is doable and 500 thous to the lucky buyer .
From Phase 1 these results are probable .
News 
Market Data 
Discover 
